TY - JOUR AU - Martín, Miguel AU - Rodríguez-Lescure, Álvaro AU - Ruiz, Amparo AU - Alba Conejo, Emilio AU - Calvo, Lourdes AU - Ruiz-Borrego, Manuel AU - Muñárriz, Blanca AU - Rodríguez, César A AU - Crespo, Carmen AU - Álava, Enrique de AU - López García-Asenjo, José Antonio AU - Guitián, María Dolores AU - Almenar, Sergio AU - González-Palacios, Jesús Fernando AU - Vera, Francisco AU - Palacios, José AU - Ramos, Manuel AU - Gracia Marco, José Manuel AU - Lluch, Ana AU - Álvarez, Isabel AU - Seguí, Miguel Ángel AU - Mayordomo, José Ignacio AU - Antón, Antonio AU - Baena, José Manuel AU - Plazaola, Arrate AU - Modolell, Alfonso AU - Pelegrí, Amadeu AU - Mel, José Ramón AU - Aranda, Enrique AU - Adrover, Encarna AU - Valero Álvarez, José AU - García Puche, José Luis AU - Sánchez-Rovira, Pedro AU - González, Sonia AU - López-Vega, José Manuel PY - 2008 DO - 10.1093/jnci/djn151 SN - 0027-8874 UR - http://hdl.handle.net/10668/749 T2 - Journal of the National Cancer Institute AB - BACKGROUNDTaxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a consequence, they have also been studied in the adjuvant setting.METHODSAfter breast cancer surgery, women with lymph node-positive disease were... LA - en PB - Oxford University Press KW - ERBB2 protein, human KW - Anciano KW - Antineoplásicos Fitogénicos KW - Protocolos de Quimioterapia Combinada Antineoplásica KW - Neoplasias de la Mama KW - Carcinoma Ductal de Mama KW - Carcinoma Lobular KW - Ciclofosfamida KW - Supervivencia sin Enfermedad KW - Esquema de Medicación KW - Epirrubicina KW - Fluorouracilo KW - Inmunohistoquímica KW - Hibridación Fluorescente In Situ KW - Infusiones Intravenosas KW - Estimación de Kaplan-Meier KW - Estadificación de Neoplasias KW - Pronóstico KW - Modelos de Riesgos Proporcionales KW - Receptor erbB-2 KW - Receptores Estrogénicos KW - Receptores de Progesterona KW - Resultado del Tratamiento KW - Marcadores Biológicos de Tumor KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged KW - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Phytogenic KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols KW - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms KW - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Carcinoma, Ductal::Carcinoma, Ductal, Breast KW - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Carcinoma, Lobular KW - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Halogenated::Mustard Compounds::Nitrogen Mustard Compounds::Phosphoramide Mustards::Cyclophosphamide KW - Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis::Disease-Free Survival KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule KW - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Doxorubicin::Epirubicin KW - Medical Subject Headings::Check Tags::Female KW - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrimidines::Pyrimidinones::Uracil::Fluorouracil KW - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans KW - Medical Subject Headings::Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biochemistry::Immunochemistry KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Histocytological Preparation Techniques::Staining and... KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Routes::Infusions, Parenteral::Infusions, Intravenous KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis::Kaplan-Meier Estimate KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Neoplasm Staging KW - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Alicyclic::Cycloparaffins::Cyclodecanes::Taxoids::Paclitaxel KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Models, Statistical::Proportional Hazards Models KW - Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2 KW - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Estrogen KW - Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::DNA-Binding Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Progesterone KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome KW - Medical Subject Headings::Chemicals and Drugs::Biological Factors::Biological Markers::Tumor Markers, Biological KW - Medical Subject Headings::Named Groups::Persons::Age Groups::Adult TI - Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. TY - research article ER -